Potential of electron beam computed tomography for coronary artery calcium screening to evaluate fatty liver: Comparison with 1H magnetic resonance spectroscopy in the Dallas Heart Study

Journal of Investigative Medicine

Volumn 59, Issue 5, 2011, Pages 780-786

  Matulevicius, Susan ^a,b   Huff, Laura C ^a,b   Szczepaniak, Lidia S ^c   Ayers, Colby R ^b   Budoff, Matthew ^d   McColl, Roderick ^a   Khera, Amit ^a,b   Peshock, Ronald M ^a,b,d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Donald W Reynolds Cardiovascular Clinical Research Center   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

Electron beam computed tomography; Hepatic steatosis; Magnetic resonance spectroscopy

Indexed keywords

CALCIUM; ALANINE AMINOTRANSFERASE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CORONARY ARTERY; CORONARY ARTERY CALCIFICATION; DIABETES MELLITUS; ELECTRON BEAM TOMOGRAPHY; FALSE NEGATIVE RESULT; FATTY LIVER; FEMALE; HUMAN; INSULIN RESISTANCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PROTON NUCLEAR MAGNETIC RESONANCE; SCREENING TEST; SENSITIVITY AND SPECIFICITY; ALANINE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED STUDY; CORONARY ARTERY CALCIUM SCORE; CRITERION RELATED VALIDITY; DIAGNOSTIC TEST ACCURACY STUDY; HYPERTENSION; LEFT LIVER LOBE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SCANNER; PREVALENCE; RIGHT LIVER LOBE; RISK FACTOR; SIGNAL NOISE RATIO; SUBCUTANEOUS FAT; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; CALCINOSIS; CARDIOVASCULAR DISEASES; COHORT STUDIES; CORONARY VESSELS; FALSE NEGATIVE REACTIONS; FATTY LIVER; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TEXAS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85047687992     PISSN: 17088267     EISSN: 17088267     Source Type: Journal    
DOI: 10.2310/JIM.0b013e318216ad1d     Document Type: Article

References (43)

1. Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology. 2002;122:1649-1657. (Pubitemid 34533559)
2. Angelico F, Del Ben M, Conti R, et al. Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease. J Clin Endocrinol Metab. 2005;90:1578-1582. (Pubitemid 40464021)
3. Targher G, Bertolini L, Padovani R, et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care. 2007;30:1212-1218. (Pubitemid 46684650)
4. McClelland RL, Chung H, Detrano R, et al. Distribution of coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2006;113:30-37. (Pubitemid 43958485)
5. Taylor AJ, Bindeman J, Feuerstein I, et al. Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: mean three-year outcomes in the Prospective Army Coronary Calcium (PACC) project. J Am Coll Cardiol. 2005;46:807-814. (Pubitemid 41224803)
6. Patel MJ, de Lemos JA, McGuire DK, et al. Evaluation of coronary artery calcium screening strategies focused on risk categories: the Dallas Heart Study. Am Heart J. 2009;157:1001-1009.
7. Assy N, Djibre A, Farah R, et al. Presence of coronary plaques in patients with nonalcoholic fatty liver disease. Radiology. 2010;254:393-400.
8. Schwenzer NF, Springer F, Schraml C, et al. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol. 2009;51:433-445.
9. Szczepaniak LS, Nurenberg P, Leonard D, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab. 2005;288:E462-E468. (Pubitemid 40110657)
10. Longo R, Pollesello P, Ricci C, et al. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging. 1995;5:281-285.
11. 1H localized magnetic resonance spectroscopy and comparison with computed tomography. Invest Radiol. 1993;28:297-302. (Pubitemid 24079682)
12. Szczepaniak LS, Babcock EE, Schick F, et al. Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol. 1999;276:E977-E989. (Pubitemid 29249618)
13. Thomsen C, Becker U, Winkler K, et al. Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging. 1994;12:487-495. (Pubitemid 24113193)
14. Cowin GJ, Jonsson JR, Bauer JD, et al. Magnetic resonance imaging and spectroscopy for monitoring liver steatosis. J Magn Reson Imaging. 2008;28:937-945.
15. Zhong L, Chen JJ, Chen J, et al. Nonalcoholic fatty liver disease: quantitative assessment of liver fat content by computed tomography, magnetic resonance imaging and proton magnetic resonance spectroscopy. J Dig Dis. 2009;10:315-320.
16. Bydder GM, Chapman RW, Harry D, et al. Computed tomography attenuation values in fatty liver. J Comput Tomogr. 1981;5:33-35. (Pubitemid 11075771)
17. Scherer U, Santos M, Lissner J. CT studies of the liver in vitro: a report on 82 cases with pathological correlation. J Comput Assist Tomogr. 1979;3:589-595. (Pubitemid 9240743)
18. Pamilo M, Sotaniemi EA, Suramo I, et al. Evaluation of liver steatotic and fibrous content by computerized tomography and ultrasound. Scand J Gastroenterol. 1983;18:743-747. (Pubitemid 13005020)
19. Victor RG, Haley RW, Willett DL, et al. The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. Am J Cardiol. 2004;93:1473-1480. (Pubitemid 38749202)
20. Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40:1387-1395. (Pubitemid 39657013)
21. Chen K, Lindsey JB, Khera A, et al. Independent associations between metabolic syndrome, diabetes mellitus and atherosclerosis: observations from the Dallas Heart Study. Diab Vasc Dis Res. 2008;5:96-101. (Pubitemid 351839280)
22. Jain T, Peshock R, McGuire DK, et al. African Americans and Caucasians have a similar prevalence of coronary calcium in the Dallas Heart Study. J Am Coll Cardiol. 2004;44:1011-1017. (Pubitemid 39165135)
23. Kodama Y, Ng CS, Wu TT, et al. Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol. 2007;188:1307-1312. (Pubitemid 46668513)
24. Horiguchi J, Nakanishi T, Ito K. Quantification of coronary artery calcium using multidetector CT and a retrospective ECG-gating reconstruction algorithm. AJR Am J Roentgenol. 2001;177:1429-1435. (Pubitemid 33081496)
25. Yoon DY, Moon JH, Kim HK, et al. Comparison of low-dose CT and MR for measurement of intra-abdominal adipose tissue: a phantom and human study. Acad Radiol. 2008;15:62-70. (Pubitemid 350217017)
26. van Werven JR, Marsman HA, Nederveen AJ, et al. Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy. Radiology. 2010;256:159-168.
27. Park SH, Kim PN, Kim KW, et al. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology. 2006;239:105-112.
28. Ricci C, Longo R, Gioulis E, et al. Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol. 1997;27:108-113. (Pubitemid 27357063)
29. Bydder GM, Kreel L, Chapman RW, et al. Accuracy of computed tomography in diagnosis of fatty liver. Br Med J. 1980;281:1042. (Pubitemid 10006909)
30. 1H-MR spectroscopy. Magn Reson Med. 2006;55:913-917.
31. Yokoo T, Bydder M, Hamilton G, et al. Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology. 2009;251:67-76.
32. Piekarski J, Goldberg HI, Royal SA, et al. Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease. Radiology. 1980;137:727-729. (Pubitemid 11203707)
33. Limanond P, Raman SS, Lassman C, et al. Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology. 2004;230:276-280. (Pubitemid 37549813)
34. Budoff MJ, Mao S, Lu B, et al. Ability of calibration phantom to reduce the interscan variability in electron beam computed tomography. J Comput Assist Tomogr. 2002;26:886-891. (Pubitemid 36076701)
35. Chau A, Gopal A, Mao S, et al. Comparison of three generations of electron beam tomography on image noise and reproducibility, a phantom study. Invest Radiol. 2006;41:522-526. (Pubitemid 44284187)
36. Davidson LE, Kuk JL, Church TS, et al. Protocol for measurement of liver fat by computed tomography. J Appl Physiol. 2006;100:864-868. (Pubitemid 43671542)
37. Speliotes EK, Massaro JM, Hoffmann U, et al. Liver fat is reproducibly measured using computed tomography in the Framingham Heart Study. J Gastroenterol Hepatol. 2008;23:894-899. (Pubitemid 351806584)
38. Ding J, Kritchevsky SB, Hsu FC, et al. Association between non-subcutaneous adiposity and calcified coronary plaque: a substudy of the Multi-Ethnic Study of Atherosclerosis. Am J Clin Nutr. 2008;88:645-650.
39. Ueda J, Kobayashi Y, Kenko Y, et al. Distribution of water, fat, and metals in normal liver and in liver metastases influencing attenuation on computed tomography. Acta Radiol. 1988;29:33-39. (Pubitemid 18088011)
40. Duman DG, Celikel C, Tuney D, et al. Computed tomography in nonalcoholic fatty liver disease: a useful tool for hepatosteatosis assessment? Dig Dis Sci. 2006;51:346-351.
41. Ishikawa I, Tateishi K, Shinoda A, et al. Changes of the hepatic CT absorption value in hemodialysis patients. J Comput Assist Tomogr. 1984;8:701-703. (Pubitemid 14097062)
42. McKenzie A, Gill G, McIntosh R, et al. Computed tomographic and ultrasound appearances of focal spared areas in fatty infiltration of the liver. Australas Radiol. 1991;35:166-168.
43. Oliva MR, Mortele KJ, Segatto E, et al. Computed tomography features of nonalcoholic steatohepatitis with histopathologic correlation. J Comput Assist Tomogr. 2006;30:37-43. (Pubitemid 43052296)